Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3

Clinical trial NCT05210504 · COMPLETED

Trial details

NCT number: NCT05210504
Sponsor: Vanderbilt University Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2022-03-09
Primary completion: 2023-01-27
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.